CX3CR1, (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/ PARC) are closely related to refractory unstable angina and can be used as a specific marker [11, 15], while CX3CL1 is used as a marker of response to statin therapy [16]. This evidence concerns the gene CCL5 and angina pectoris.